CTNNB1 and benign neoplasm: The CTNNB1 gene as well as the hair matrix cells seem to be preferentially targeted by the unknown genetic defect as pilomatricoma is a rare benign neoplasm and other potential CTNNB1 driven neoplasms do not seem to be more frequent in DM1 patients with the exception of endometrial cancer.